A multicenter study on optimizing piperacillin-tazobactam use: lessons on why interventions fail.

Gaynes, Robert P; Gould, Carolyn V; Edwards, Jonathan; Antoine, Theresa L; Blumberg, Henry M; Desilva, Kathryn; King, Mark; Kraman, Alice; Pack, Jan; Ribner, Bruce; Seybold, Ulrich; Steinberg, James; Jernigan, John A

Gaynes, Robert P; Gould, Carolyn V; Edwards, Jonathan; Antoine, Theresa L; Blumberg, Henry M; Desilva, Kathryn; King, Mark; Kraman, Alice; Pack, Jan; Ribner, Bruce; Seybold, Ulrich; Steinberg, James; Jernigan, John A.

Affiliation

Gaynes RP; Centers for Disease Control and Prevention, Emory University School of Medicine, Atlanta Veterans' Affairs Medical Center, GA, USA. rgaynes@cdc.gov

Infect Control Hosp Epidemiol ; 30(8): 794-6, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19530943

Subject(s)

Anti-Bacterial Agents/therapeutic use; Practice Patterns, Physicians'; Colony Count, Microbial; Drug Resistance, Bacterial; Drug Utilization/statistics & numerical data; Focus Groups; Health Knowledge, Attitudes, Practice; Hospitals, University; Hospitals, Veterans; Humans; Microbial Sensitivity Tests; Penicillanic Acid/analogs & derivatives; Penicillanic Acid/therapeutic use; Piperacillin/therapeutic use; Piperacillin, Tazobactam Drug Combination

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Practice Patterns, Physicians' / Anti-Bacterial Agents Type of study: Clinical_trials / Qualitative_research Limits: Humans Language: En Journal: Infect Control Hosp Epidemiol Journal subject: DOENCAS TRANSMISSIVEIS / ENFERMAGEM / EPIDEMIOLOGIA / HOSPITAIS Year: 2009 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google